AZD1152
目录号: A15011
Aurora B 抑制剂
AZD1152 是一种前药,它在血清中迅速经过磷酸酶介导的裂解,释放出 barasertib-hQPA,这是一种选择性的 Aurora B 激酶抑制剂,在急性髓性白血病(AML)患者的临床研究中显示出初步活性。
Discription | AZD1152 is a pro-drug that rapidly undergoes phosphatase-mediated cleavage in serum to release barasertib-hQPA, a selective Aurora B kinase inhibitor that has shown preliminary activity in clinical studies of patients with acute myeloid leukemia (AML). | |||||
---|---|---|---|---|---|---|
Targets |
|
|||||
Cell Research |
|
目录号 | A15011 |
---|---|
分子式 | C26H31FN7O6P |
分子量 | 587.54 |
CAS号 | 722543-31-9 |
SMILES | CCN(CCCOC1=CC2=C(C=C1)C(=NC=N2)NC3=NNC(=C3)CC(=O)NC4=CC(=CC=C4)F)CCOP(=O)(O)O |
其他名称 | Barasertib, AZD-1152, AZD 1152 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2